Greenberg Traurig's Joseph F. Coniglio to Present at the 27th Annual Course on Advanced Medical Torts
Joseph F. Coniglio, managing shareholder of global law firm Greenberg Traurig, LLP's Dallas office, will speak at the virtual 27th Annual Course on Advanced Medical Torts on March 25 at 3:00 PM CT.
DALLAS, March 23, 2021 /PRNewswire-PRWeb/ -- Joseph F. Coniglio, managing shareholder of global law firm Greenberg Traurig, LLP's Dallas office, will speak at the virtual 27th Annual Course on Advanced Medical Torts on March 25 at 3:00 PM CT.
Coniglio's presentation will analyze the "piercing of the corporate veil" theory of liability, as well as the "alter ego" doctrine which impacts Texas companies in the health care industry. He will address the factors considered by Texas courts when evaluating corporate veil piercing, and the statutory requirements as well as limitations as set forth in the Texas Business Organizations Code. Coniglio will be presenting alongside attorney Michael Sawicki.
"It is an honor to have the opportunity to speak to my colleagues in the Texas Bar at the Annual Course on Advanced Medical Torts," Coniglio said. "The event over the years has been a leading conference for those practicing in the health care litigation area, and offers relevant content as well as timely updates in this complex area to attendees."
The conference is hosted by the Texas Bar Continuing Legal Education (CLE) program and will offer 11.75 hours of credit (including 3 hours ethics). Texas Bar CLE is regulated by the MCLE department.
Coniglio is a shareholder in the Health Care & FDA Practice. He has wide-ranging experience in the areas of health care law and complex business litigation. He utilizes his 20-plus years of experience in the health care industry to assist a wide variety of health care related entities and providers, including hospitals, physician groups, and long term care facilities, as well as clinical labs and pharmacies in litigation and regulatory matters.
About Greenberg Traurig's Health Care & FDA Practice: Greenberg Traurig's multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm's capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.
About Greenberg Traurig, LLP – Texas: Texas is important to Greenberg Traurig, LLP and part of its history. With approximately 130 Texas lawyers in Austin, Dallas, and Houston, Greenberg Traurig has deep roots in the Texas business, legal, and governmental communities. Greenberg Traurig Texas works with clients to address their interdisciplinary legal needs across the state utilizing the firm's global platform. The Texas attorneys are experienced in industries key to the state's future, including: aviation, chemicals, construction, education, energy and natural resources, financial institutions, health care, hedge funds, hospitality, infrastructure, insurance, media, medical devices, pharmaceutical and biotechnology, real estate, retail, sports, technology and software, telecommunications, transportation, and video games and esports.
About Greenberg Traurig: Greenberg Traurig, LLP (GT), has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: http://www.gtlaw.com
Media Contact
Lourdes Brezo Martinez, Greenberg Traurig, LLP, +1 212.801.2131, [email protected]
SOURCE Greenberg Traurig, LLP
Share this article